Clinical trials results demonstrate value of home OCT at international meetings
February 22, 2023 08:00 ET
|
Notal Vision
Manassas, VA, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Notal Vision, Inc. reported today that the latest data on its investigational home-based optical coherence tomography (OCT) and how the service can be...
Digital home monitoring shows unique predictive value in disease progression for AMD patients
October 25, 2022 08:00 ET
|
Notal Vision
Manassas, VA, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Notal Vision, Inc. reported today the publication of the second report of the Analysis of Long-term visual Outcomes of ForeseeHome Remote...
Efficacy of Notal Vision Home OCT demonstrated by a series of scientific and clinical work
June 29, 2022 08:00 ET
|
Notal Vision
Manassas, VA, June 29, 2022 (GLOBE NEWSWIRE) -- Notal Vision, Inc. reported today that numerous scientific and clinical publications and presentations prove the feasibility and efficacy of their...
Retrospective study covering 2,000 patients over 10 years using ForeseeHome AMD remote monitoring shows substantially better outcomes for patients
April 26, 2022 08:49 ET
|
Notal Vision
Manassas, VA, April 26, 2022 (GLOBE NEWSWIRE) -- Notal Vision, Inc. reported today the publication of the Analysis of Long-term visual Outcomes of ForeseeHome Remote Telemonitoring (ALOFT) study...
Notal Vision Reports Publication of First U.S. Home OCT Study Results
March 08, 2022 09:48 ET
|
Notal Vision
Manassas, VA, March 08, 2022 (GLOBE NEWSWIRE) -- Manassas, VA (March 8th, 2022) – Digital healthcare provider Notal Vision today announced that results of the first U.S.-based study with its...
Notal Vision Monitoring Center Reports AI Analysis of 10 Million ForeseeHome® AMD Home Monitoring Tests
November 30, 2021 08:00 ET
|
Notal Vision
Manassas, VA, Nov. 30, 2021 (GLOBE NEWSWIRE) -- The Notal Vision Monitoring Center celebrates the artificial intelligence (AI) based analysis of the ten millionth test performed by over 20,000...
Notal Vision Reports Results from First U.S. Home OCT Feasibility Study
October 12, 2021 08:00 ET
|
Notal Vision
Manassas, VA, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Notal Vision, Inc. reported today that results of the first U.S.-based feasibility study with its investigational home-based optical coherence...
Notal Vision announces publication of first prospective longitudinal pilot study of daily self-imaging with patient-operated Home OCT in wet AMD patients
July 13, 2021 08:00 ET
|
Notal Vision
Manassas, VA, July 13, 2021 (GLOBE NEWSWIRE) -- Notal Vision, Inc. announced today that results from the first prospective longitudinal pilot study of daily, home-based self-imaging with their...
Notal Vision raises up to $60 million to support development of its Home OCT technology and commercial growth of its ForeseeHome AMD Monitoring Program
June 01, 2021 08:00 ET
|
Notal Vision
Manassas, VA, June 01, 2021 (GLOBE NEWSWIRE) -- Notal Vision, Inc., a privately held ophthalmic home monitoring services provider focused on early disease detection and treatment monitoring is...
ForeseeHome AMD home monitoring real-world data analysis demonstrates substantial benefit for patients’ vision
April 06, 2021 08:00 ET
|
Notal Vision
Manassas, VA, April 06, 2021 (GLOBE NEWSWIRE) -- Real-world data on the performance of the ForeseeHome® AMD Monitoring Program, a home-based diagnostic that helps detect the conversion from...